A study of MET concordance and gene profiling in 1L NSCLC (Genomet)

Trial Identifier:	D5162L00064
Sponsor:	AstraZeneca
Start Date:	June 2026
Primary Completion Date:	March 2027
Study Completion Date:	March 2027
Condition:	Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
China	Beijing, China
China	Shanghai, China

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.